Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.
Arbyn M, Cuschieri K, Bonde J, Schuurman R, Cocuzza C, Broeck DV, Zhao FH, Rezhake R, Gultekin M, de Sanjosé S, Canfell K, Hawkes D, Saville M, Hillemanns P, Dillner J, Berkhof J, Prétet JL, Gheit T, Clifford G, Basu P, Almonte M, Wentzensen N, Poljak M. Arbyn M, et al. Among authors: schuurman r. J Med Virol. 2024 Sep;96(9):e29881. doi: 10.1002/jmv.29881. J Med Virol. 2024. PMID: 39221498 Review.
European guidelines on the clinical management of HIV-1 tropism testing.
Vandekerckhove LP, Wensing AM, Kaiser R, Brun-Vézinet F, Clotet B, De Luca A, Dressler S, Garcia F, Geretti AM, Klimkait T, Korn K, Masquelier B, Perno CF, Schapiro JM, Soriano V, Sönnerborg A, Vandamme AM, Verhofstede C, Walter H, Zazzi M, Boucher CA; European Consensus Group on clinical management of tropism testing. Vandekerckhove LP, et al. Lancet Infect Dis. 2011 May;11(5):394-407. doi: 10.1016/S1473-3099(10)70319-4. Epub 2011 Mar 21. Lancet Infect Dis. 2011. PMID: 21429803 Free article. Review.
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Hamers RL, Sigaloff KC, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Stevens WS, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance (PASER). Hamers RL, et al. Among authors: schuurman r. Clin Infect Dis. 2012 Jun;54(11):1660-9. doi: 10.1093/cid/cis254. Epub 2012 Apr 3. Clin Infect Dis. 2012. PMID: 22474222
[Consensus Statement on deep brain stimulation for treatment-resistant obsessive-compulsive disorder].
Mocking RJT, Ackermans L, Bergfeld IO, Bot M, van Dijk JMC, Goossens L, Haarman BCM, de Koning PP, Leentjens AFG, Linden DEJ, van den Munckhof P, Namavar Y, Oterdoom DLM, Ho Pian KL, van Rooijen G, Schruers KRJ, Schuurman R, Temel Y, Vulink NCC, Denys D. Mocking RJT, et al. Among authors: schuurman r. Tijdschr Psychiatr. 2024;66(7):387-394. Tijdschr Psychiatr. 2024. PMID: 39463322 Free article. Dutch.
Validation of the hotspot for dorsolateral subthalamic nucleus targeting in deep brain stimulation surgery for Parkinson's disease: a post hoc analysis of a randomised controlled trial.
Bolier E, Holewijn R, De Bie RMA, Beudel M, van den Munckhof P, Schuurman R, Bot M. Bolier E, et al. Among authors: schuurman r. J Neurol Neurosurg Psychiatry. 2024 Jul 20:jnnp-2023-333164. doi: 10.1136/jnnp-2023-333164. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39033020 Free article.
322 results